Use of liraglutide in the patient with obesity and type 2 diabetes mellitus: a literature review

Simple item page
dc.contributor.authorCancino, J. A. D.en_US
dc.contributor.authorÁlvarez, C. J. S.en_US
dc.contributor.authorRamírez, K. A. Z.en_US
dc.date.accessioned2024-09-24T06:10:29Z
dc.date.available2024-09-24T06:10:29Z
dc.date.issued2023-10
dc.description.abstractObesity and type 2 diabetes mellitus represent two of the most pressing public health challenges globally. In recent decades, an alarming increase in the prevalence of both conditions has been observed, which has led to a significant increase in the burden of disease and an increased search for effective therapeutic strategies. As evidence accumulates on the efficacy and safety of Liraglutide in this patient population, a comprehensive review of the available scientific literature is necessary. The objective of this literature review is to analyze and synthesize relevant studies investigating the use of liraglutide in patients with obesity and type 2 diabetes mellitus, in order to provide a comprehensive view on its effectiveness, indications, complications and management. In conclusion, the use of liraglutide in patients with obesity and type 2 diabetes mellitus has been shown to be an effective therapeutic option to improve glycemic control, promote weight loss and reduce cardiovascular risk. This drug, as a GLP-1 receptor agonist, stimulates insulin secretion, suppresses excessive glucagon release and delays gastric emptying, which contributes to the improvement in glycemic control.en_US
dc.identifier.affiliationsDepartamento De Medicina Interna, Instituto Mexicano Del Seguro Social, Jesús María, Aguascalientes, Mexicoen_US
dc.identifier.affiliationsDepartamento De Medicina Interna, Instituto Mexicano Del Seguro Social, Jesús María, Aguascalientes, Mexicoen_US
dc.identifier.affiliationsDepartamento De medicina interna, Instituto Mexicano del Seguro Social, Mérida, Yucatán, Mexicoen_US
dc.identifier.citationCancino J. A. D., Álvarez C. J. S., Ramírez K. A. Z.. Use of liraglutide in the patient with obesity and type 2 diabetes mellitus: a literature review. International Journal of Basic & Clinical Pharmacology. 2023 Sept; 12(5): 755-758en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/226579
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber5en_US
dc.relation.volume12en_US
dc.source.urihttps://doi.org/10.18203/2319-2003.ijbcp20232577en_US
dc.subjectLiraglutideen_US
dc.subjectDiabetes mellitusen_US
dc.subjectGLP-1 receptoren_US
dc.titleUse of liraglutide in the patient with obesity and type 2 diabetes mellitus: a literature reviewen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijbcp2023v12n5p755.pdf
Size:
206.04 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Basic & Clinical Pharmacology